Gilead Sciences Inc (GILD)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 19,330,000 | 18,474,000 | 18,281,000 | 17,539,000 | 22,749,000 | 22,242,000 | 21,094,000 | 20,939,000 | 21,209,000 | 21,057,000 | 20,236,000 | 19,915,000 | 21,064,000 | 21,471,000 | 19,710,000 | 18,964,000 | 18,221,000 | 17,471,000 | 18,142,000 | 22,179,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $19,330,000K)
= 0.00
The debt-to-capital ratio for Gilead Sciences Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt financing to raise capital, or if it has any debt, it forms an insignificant portion of its overall capital structure. A debt-to-capital ratio of 0.00 signifies that the company's capital is primarily derived from equity rather than debt, reflecting a low financial risk associated with debt obligations. While a low or zero debt-to-capital ratio can suggest financial stability and a conservative approach to financing, it may also signal missed opportunities for leveraging debt to potentially enhance returns for shareholders.
Peer comparison
Dec 31, 2024